Clinical Trials Browser

Carcinoma, Renal Cell

Urinary Bladder Neoplasms

Carcinoma, Renal Cell, Lymphatic Metastasis

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Carcinoma, Transitional Cell

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Biochemically Recurrent Prostate Cancer

Non-Muscle Invasive Bladder Neoplasms

Neoplasms, Urologic Neoplasms

Prostatic Neoplasms

Prostate Adenocarcinoma

Prostatic Neoplasms, Castration-Resistant

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

Prostatic Neoplasms

Carcinoma, Carcinoma, Renal Cell

Urinary Bladder Neoplasms

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Prostatic Neoplasms

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Prostatic Neoplasms, Castration-Resistant

Metastatic Castrate-sensitive Prostate Cancer

Prostate Cancer Screening

Prostatic Neoplasms

Prostatic Neoplasms

Metastatic Castration-resistant Prostate Cancer

Prostate Cancer Metastatic

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

Prostatic Neoplasms

Prostatic Neoplasms

Urothelial Cancer

Neoplasms, Prostatic Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

Prostatic Neoplasms

Prostatic Neoplasms, Recurrence

Metastatic Castration-Resistant Prostate Cancer

Carcinoma, Renal Cell

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Prostatic Neoplasms

Neoplasms, Prostatic Neoplasms

Carcinoma, Transitional Cell

Prostatic Neoplasms

Clinical Trials

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

ABLE-32

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

AMPLIFY

ADVANCED-3

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

ARASTEP

SunRISe-5

RESCUE

RADVAN

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

MAGNITUDE

BOND-003

CLARIFY

LITESPARK-033

NIAGARA

PRIMORDIUM

MoonRISe-1

MoonRISe-3

MK-2400-001

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

KLK2-PASenger

LIBERTAS

MUSIC-Screen

PSMAddition

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)

OMAHA-003

RESCUE

KEYNOTE-564

MK-5684-004

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

CheckMate901

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

FORAGER-2

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

MEVPRO-1

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

STRIKE

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

GAIN-BCG

MEVPRO-3

PRIMARY2

A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging